News

Fully remote • 24–30 hours/week • $100/hour + GST Use your clinical skills, develop expertise in weight management and support patients across New Zealand, all from home. Pocket Lab is a New Zealand telehealth service helping patients nationwide. We’re looking for a Nurse Practitioner to join our online weight management team. You’ll work alongside our GP team, with all the required training and ongoing support provided. What’s on offer: ● Guaranteed regular hours ● Monday to...

Kia ora. Following significant consultation and engagement, Pharmac is making changes to the Pharmaceutical Schedule relating to antiretroviral medicines used in the treatment and prevention of HIV. What is changing Removal of Special Authority requirements: From 1 November 2026, there will no longer be a Special Authority requirement for funded antiretroviral treatment for any indication. The removal of Special Authority requirements is intended to reduce administrative burden. It does...

Please see below updates from Pharmac. Supply issue Pimafucort Ointment Pioglitazone tab 15 mg and tab 30 mg (Vexazone) Vannair Metered dose inhalers (budesonide/eformoterol) Brand change Coversyl tabs salt change Discontinuation Epilim tab 100 mg crushable date extended 1.Supply issue: Pimafucort Ointment There is an upcoming long-term supply issue affecting Pimafucort ointment. The supplier has advised that due to a significant manufacturing issue affecting an ingredient used in...

Pharmac has made changes to improve access to funded HIV medicines, making it easier for people living with HIV, or at risk of acquiring HIV, to access treatment when they need them. From 1 November 2026, people will no longer need to meet Special Authority or Hospital Restriction criteria to access funded antiretroviral medicines. We've also made two antiretroviral medicines, emtricitabine with tenofovir disoproxil and dolutegravir, available on a Practitioner's Supply Order (PSO) for...

Pharmac has made changes to improve access to funded HIV medicines, making it easier for people living with HIV, or at risk of acquiring HIV, to access treatment when they need them. From 1 November 2026, people will no longer need to meet Special Authority or Hospital Restriction criteria to access funded antiretroviral medicines. We've also made two antiretroviral medicines, emtricitabine with tenofovir disoproxil and dolutegravir, available on a Practitioner's Supply Order (PSO) for...

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 16 October 2026. It includes information on: New updates Discontinuations New updates Discontinuation date change: Epilim Crushable 100 mg tablets Pharmac would like to inform you that we have secured additional supply of Epilim Crushable 100 mg tablets through to December next year (2027). We are working to identify alternative options for people who are...